Skip to content

Contact +44 (0) 20 7060 7474 email us

Healthcare

GenVec, Inc. - Financial and Strategic Analysis Review

 

Publication Date June 2009
Publisher Global Markets Direct
Product Type Report
Pages 16
ISBN Number not applicable
Product Code GMD02134

Price

£83.00
approximately: $126 | €93

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

GenVec, Inc. - Financial and Strategic Analysis Review

GenVec Inc. is a biopharmaceutical company engaged in developing novel gene-based therapeutic drugs and vaccines. The company's product candidates TNFerade intended for the treatment of pancreatic cancer, AdPEDF for the treatment of macular degeneration and TherAtoh for hearing & balance loss are in clinical stages and utilize a common patent-protected technology platform. The company also develops vaccines for infectious diseases such as HIV, malaria, seasonal and pandemic flu, HSV-2, and foot and mouth disease using its proprietary adenovector technology. The company is headquartered in Maryland, United States.

Global Markets Direct's GenVec, Inc. - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of GenVec, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

  • Provides key company information for business intelligence needs.
  • The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
  • The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
  • The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
  • The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
  • Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

  • A quick "one-stop-shop" to understand the company.
  • Enhance business/sales activities by understanding customers' businesses better.
  • Get detailed information and financial and strategic analysis on companies operating in your industry.
  • Identify prospective partners and suppliers - with key data on their businesses and locations.
  • Capitalize on competitor's weaknesses and target the market opportunities available to them.
  • Compare your company's financial trends with those of your peers / competitors.
  • Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Contents

  • Key Information
  • Key Ratios
  • Share Data
  • Performance Chart
  • List of Tables
  • List of Figures
    • Key Facts
    • Business Description
    • Major Products and Services
    • Overview
    • History
    • SWOT Analysis Overview
    • Overview
    • GenVec, Inc. - Strengths
    • Fast Track Designation to TNFerade
    • Adenovirus Vector Technology
    • Patent Protected Portfolio
    • GenVec, Inc. - Weaknesses
    • Losses from Operational Activities
    • Dependence on the Collaborative Agreements
    • GenVec, Inc. - Opportunities
    • Large Cancer Treatment Market
    • Rising Healthcare Expenditure in the US
    • Potential of TNFerade for Other Cancers
    • GenVec, Inc. - Threats
    • Competitive Biopharmaceuticals Market
    • Tightening of FDA's Regulatory Oversight
    • Risk of Delay in Manufacturing Operations
    • Key Competitors
    • Key Employees
    • Key Employee Biographies
    • Company Statement
    • Locations And Subsidiaries
    • Head Office
    • Financial Ratios
    • Capital Market Ratios
    • Annual Ratios
    • Interim Ratios
    • Ratio Charts
  • Appendix
    • Methodology
    • Ratio Definitions
    • About Global Markets Direct
    • Contact Us
    • Disclaimer
  • List of Tables
    • GenVec, Inc., Key Facts
    • GenVec, Inc., Key Ratios
    • GenVec, Inc., Share Data
    • GenVec, Inc., Key Facts
    • GenVec, Inc., History
    • GenVec, Inc., Key Employees
    • GenVec, Inc., Key Employee Biographies
    • GenVec, Inc., Ratios based on current share price
    • GenVec, Inc., Annual Ratios
    • GenVec, Inc., Interim Ratios
    • Currency Codes
    • Capital Market Ratios
    • Equity Ratios
    • Profitability Ratios
    • Cost Ratios
    • Liquidity Ratios
    • Leverage Ratios
    • Efficiency Ratios
  • List of Figures
    • GenVec, Inc., Performance Chart (2004 - 2008)
    • GenVec, Inc., Ratio Charts
Product Features / Use
Scope Expert Insight/Opinion
Profiles In-depth Company Insight
Features Contains SWOT Analysis